Biohaven Ltd. (BHVN) is a Biotechnology company in the Healthcare sector, listed on New York Stock Exchange. This page provides the complete earnings calendar, dividend schedule, and financial data for Biohaven Ltd. in 2026. The next earnings report is expected on November 17, 2026.
Next earnings date
17 Nov 2026
In 88 days
EPS estimate
-0.72
Revenue estimate
0
Past earnings
Latest earnings analysis
Biohaven Ltd. missed consensus on EPS, recording EPS of -$0.91 versus an estimate of -$0.761, while revenue met expectations at $0. In the prior quarter both EPS and revenue missed expectations, with revenue coming in 100.0% below estimates.
No dividend history available.
Biohaven Ltd. is a clinical-stage biopharmaceutical company. The Company focuses on development of therapies for neurological and immunoscience diseases that can change current treatment paradigms.
Biohaven Ltd. (BHVN) is scheduled to report earnings on November 17, 2026.
Biohaven Ltd. (BHVN) last reported earnings on August 10, 2026.
Biohaven Ltd. (BHVN) is listed on New York Stock Exchange.
We use cookies to make our website work and improve your experience. With your consent, we also use cookies for analytics and advertising.